• Fresenius Medical Care appointed Cassie McLean to its Management Board, effective Aug. 1, 2026.
• McLean will lead the Care Delivery segment as CEO, taking direct accountability for the global clinic business.
• She replaces Craig Cordola as CEO of Care Delivery.
• McLean joined the group in August 2025 as president of Fresenius Kidney Care.
• She previously served as CEO of Monte Nido, following nearly 16 years at DaVita Kidney Care, including as group vice president.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FMC - Fresenius Medical Care AG published the original content used to generate this news brief on August 03, 2026, and is solely responsible for the information contained therein.